Press Releases
Bioneer Announces Patent Approval for SRN-001 Obesity Treatment Composition in Japan, Following Sout
관리자 / 2024-09-02
Bioneer
Announces Patent Approval for SRN-001 Obesity Treatment Composition in Japan,
Following South Korea and Russia
- Plans to expand
indications from antifibrotic therapy to obesity treatment following completion
of Phase 1 clinical trial and advancement to Phase 2.
- Preclinical studies show
approximately 70% reduction in visceral fat in obese mouse models compared to
control group.